In the first personal injury case that has gone to trial over Zantac, GSK and Boehringer Ingelheim have emerged with an important victory as a Chicago jury has rejected the claim of Angela Valadez ...

An Illinois jury sided with drugmakers GlaxoSmithKline and Boehringer Ingelheim in the first trial over Zantac, which the FDA recalled in 2020 over claims the over-the-counter heartburn medication ...

(Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether Boehringer ...

The verdict, in a case brought by plaintiff Angela Valadez, comes two years after a federal judge tossed all the plaintiffs' experts in the Zantac multidistrict litigation. Additional Zantac jury ...

FRANKFURT, June 20 (Reuters) - Sanofi SASY.PA said on Tuesday that the International Chamber of Commerce rejected rival drugmaker Boehringer Ingelheim's (BI) claims to be indemnified by Sanofi in ...

Pfizer, GSK, Sanofi and Boehringer Ingelheim are now able to wash their hands of thousands of Zantac-related lawsuits after a federal judge in Florida ruled that the claims against the companies weren ...

Drugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding the cancer risks of their once-blockbuster heartburn drug Zantac, according to lawyers representing ...

PARIS, Jan 4 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Wednesday its dispute with Germany's Boehringer Ingelheim over potential liability for cancer claims in the United ...

Sanofi defeated Boehringer Ingelheim GmbH in an arbitration proceeding over legal responsibilities tied to controversial heartburn medicine Zantac. The French drugmaker is not liable to indemnify BI ...

SAN FRANCISCO (MarketWatch) -- Boehringer Ingelheim Pharmaceuticals Inc. after Thursday's bell said it has agreed with Johnson & Johnson and Pfizer Inc. to buy the U.S. rights to the over-the-counter ...

FRANKFURT, June 20 (Reuters) - Sanofi SASY.PA said on Tuesday that the International Chamber of Commerce ruled in its favour in an arbitration case over claims by Boehringer Ingelheim that Sanofi ...